
Veracyte VCYT
$ 36.82
0.25%
Quarterly report 2025-Q3
added 11-05-2025
Veracyte P/S Ratio 2011-2026 | VCYT
Annual P/S Ratio Veracyte
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.73 | 5.67 | 12.7 | 26.5 | 10.2 | 7.11 | 3.06 | 3.3 | 3.4 | 4.59 | 2.82 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 26.5 | 2.82 | 7.65 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
35.6 | $ 2.95 | 10.3 % | $ 166 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Amarin Corporation plc
AMRN
|
1.43 | $ 15.08 | 2.24 % | $ 6.15 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.51 | -1.68 % | $ 8.45 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 222.25 | 0.1 % | $ 5 B | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 109.88 | -0.42 % | $ 27.2 B | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.21 | 2.56 % | $ 1.48 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 2.64 | 7.99 % | $ 3.08 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.4 | 2.8 % | $ 9.57 B | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.44 | -1.37 % | $ 367 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 14.79 | 1.83 % | $ 4.57 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B |